Health & Medicine
-
KEYNOTE-B49 Shows Pembrolizumab Delays Progression in PD-L1-Positive Breast Cancer
New data from the phase 3 trial indicate that adding immunotherapy to chemotherapy improves progression-free survival in a specific subset of advanced…
-
Flawed Studies Prompt Hormone Therapy Caution for Breast Cancer Survivors
Recent reevaluations of past studies suggest hormone therapy may be safer for breast cancer survivors than previously thought, but doctors remain cautious.
-
Great Lakes: Over 6,400 Oil Spills Over a Decade
A new study reveals thousands of small oil spills in the Great Lakes, raising concerns about their long-term ecological impact.
-
October FDA Approvals Beyond Cancer: Hives, Schizophrenia, Eye Disease, Hepatitis B and Crohn Disease
From allergy to ophthalmology, new October treatments bring first-in-class options and at-home therapies for chronic conditions and rare diseases.
-
How Early-Stage Breast Cancer Is Treated: Surgery, Radiation and Whole-Body Therapy
MANILA, July 2 — For families across Asia facing a breast cancer diagnosis, the word “early” carries immense weight. In the early…
-
How New Immunotherapy Aims to Break the Cycle of Surgery for RRP Patients
The FDA has approved VOCERYQ, a novel DNA-based immunotherapy designed to reduce the need for repeated surgical interventions in adults with RRP.
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
Abu Dhabi startup BioSapien doses first patient in Phase I trial evaluating its biodegradable MediChip implant to deliver localized chemotherapy directly to…
-
FDA Approves Tirzepatide to Reduce Heart Attack Risk in Type 2 Diabetes
The FDA has approved tirzepatide (Mounjaro) for cardiovascular risk reduction, marking a shift from glucose-only control to comprehensive heart protection based on…
-
UK Trial Aims to Cut Breast Cancer Radiotherapy from Three Weeks to Five Days
Government-funded FAST-Forward Boost trial recruits 1,000 patients across 39 hospitals to test shorter treatment with targeted boost dose.
-
Waters and Labcorp partner to expand FDA-approved HPV testing options by late 2026
Diagnostic leaders aim to reshape cervical cancer screening availability through a nationwide network offering comprehensive genotyping via clinician-collected and at-home samples.
-
Hospital Beds for Critically Ill Kids Vanish as Costs Rise
Nationwide closures of pediatric units convert beds to adult care, forcing families to travel hours for lifesaving treatment.
-
RFK Jr. Orders FDA to Allow Unapproved Peptide Injections
Health Secretary Robert F. Kennedy Jr. orders the FDA to halt enforcement on six unapproved wellness peptides, prompting safety concerns from scientists…
-
New Study Shows Tucatinib Delays Progression in Breast Cancer Spread to Brain
A Duke-led trial found adding tucatinib to standard care substantially delayed worsening in HER2-positive breast cancer patients with new brain metastases.
-
FDA Draft Guidance Would Let Individualized Gene Editing Variants Share One License Application
New regulatory framework aims to streamline submissions for multiple gene therapy variants under a single application, addressing critical gaps in oversight for…
-
Alzheimer’s Association Puts 2026 U.S. Toll at 7.4 Million Americans Aged 65 and Older
WASHINGTON, July 15 — The strategic calculus around Alzheimer’s disease is shifting, but the underlying numbers remain stark. As of 2026, the…
-
GSK to Nearly Double Cancer Drugs in Trials as It Rebuilds Oncology Ahead of HIV Patent Cliff
Amidst looming patent expirations for HIV blockbusters, GSK is aggressively expanding its oncology pipeline, aiming to double late-stage cancer drug studies by…
-
Talazoparib and Enzalutamide Combination Moves Earlier in Prostate Cancer Treatment
Talazoparib, marketed under the brand name Talzenna, is a significant medication in the fight against cancer, specifically breast and prostate cancer. As…
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
Court rulings on liability and funding disputes force patients to wait years for verdicts, while Medicare recovery rules threaten to consume settlement…
-
Stanford Digital Twins Point to a Drug Pair That May Delay Preterm Labor
Researchers use immune system simulations to find a drug pair that delays labor 15 times better than aspirin alone, offering hope for…
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
MSI-H status identifies rectal cancer patients who may avoid surgery via dostarlimab, a new FDA-approved immunotherapy targeting defective DNA repair.
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
A smooth protein surface and high GTP affinity stymied drugmakers until a cysteine at G12C enabled covalent inhibitors like divarasib.
-
Rural Cancer Death Gap Persists as National Rates Fall, Reports Show
For nearly three decades, the United States has seen cancer death rates fall. The turnaround began in 1991. But the gains have…
-
Roche’s Divarasib Shows Superiority in Lung Cancer Trial
BASEL, July 2 — A phase III trial filed by Roche shows its investigational drug divarasib outperformed approved KRAS G12C inhibitors in…
-
Long COVID Linked to 14 Percent Higher Risk of New High Blood Pressure, Swedish Study Finds
Discover the new study linking Long COVID to a 14 percent higher risk of hypertension, and learn why cardiovascular monitoring matters now.
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992